[Pharmacological and clinical profile of Bortezomib (Velcade)].
Fujii
Hideji
H
hfujii@janjp.jnj.com
Kotobuki
Yoshitaka
Y
Nomura
Shunji
S
Harada
Yasushi
Y
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001897:Boronic Acids / Q000494:pharmacology* / Q000627:therapeutic use*; D000069286:Bortezomib; D006801:Humans; D011480:Protease Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D011719:Pyrazines / Q000494:pharmacology* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib